GLP1 - Agonists Flashcards
Brand name for liraglutide
Victoza
Brand name for dulaglutide
Trulicity
Brand name for semaglutide
Oxen pic and rybelsius
Brand name for exenatide
Byetta. Bydureon
Brand name for lixisenatide
Adylyxin
Efficacy of GLP1
Reduces A1C by 0.7% to 1.6 %. Decreases weight by up to 6kg
Advantage of GLP in terms of hypoglycemia
Leads to insulin release in presence of elevated glucose so it decreases chances of hypoglycemia
How GLP1 works
Inhibits glucagon secretion, delays gastric emptying, decreases appetite
GLP1 function
Promotes satiety which decreases appetite. Slows gastric emptying. Decease glucose output from the liver.
If patient can afford GLP- 1 and they are on insulin. What is recommended
Add GLP-1
Recommendations for GLP1 in terms of therapy
Recommended as initial therapy for type 2 with or at high risk for ASVD, HF, and CKD. In T2DM, it is preferred to insulin if patient can afford
Adverse effects of GLP-1
Nausea and vomiting. Counter indicated in chronic pancreatitis. Counter-indicated in medullary thyroid cancer or FMH of MTC and MEN2. Avoid patients with gastroparesis. Avoid use in patients with gall bladder disease
Advantages of tirzapeptide
Enhances first and second generation of insulin secretion. Reduces glucagon levels, in a glucose dependent manner. Delays gastric emptying. Increases satiety. Causes weight loss of about 11kg. Decreases by A1C by 1.5% to 2.3%
Adverse effects of Tirzapeptide
N/V/D. Pancreatitis thyroid tumors. Gallbladder disease. Tachycardia
Dosing for tirzapeptide
2.5 mg SQ weekly. Adjust by 0.25 mg/week increments up to 15 mg SQ weekly